Critical Reviews in Oncology Hematology

Papers
(The H4-Index of Critical Reviews in Oncology Hematology is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Harnessing tumor metabolism during cancer treatment: A narrative review of emerging dietary approaches261
Comparative efficacy of first-line therapies for PD-L1-negative advanced NSCLC: A network meta-analysis with reconstructed survival curves175
Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies138
The role of cGAS-STING in remodeling the tumor immune microenvironment induced by radiotherapy128
Systemic immune-inflammation index as a predictor of survival in non-small cell lung cancer patients undergoing immune checkpoint inhibition: A systematic review and meta-analysis125
Current status of locally advanced rectal cancer therapy and future prospects102
Development of treatment strategies for advanced HER2-positive gastric cancer: Insights from clinical trials99
Tyrosine kinase inhibitors in cancers: Treatment optimization – Part II87
A non-invasive miRNA-based approach in early diagnosis and therapeutics of oral cancer85
Stereotactic body radiotherapy as an alternative to brachytherapy in cervical cancer (SCORE): A systematic review and meta-analysis77
Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study76
Double agents in immunotherapy: Unmasking the role of antibody drug conjugates in immune checkpoint targeting73
Apigenin in cancer prevention and therapy: A systematic review and meta-analysis of animal models73
Microbiome dynamics in breast cancer: Mechanisms, therapeutic impacts and research gaps71
Novel bioengineered drugs with immunotherapies for malignant pleural effusion: Remodulate tumor immune microenvironment and activate immune system70
Real-world analysis of primary central nervous system diffuse large B-cell lymphoma65
Advancing tumor vaccines: Overcoming TME challenges, delivery strategies, and biomaterial-based vaccine for enhanced immunotherapy64
Novel insight into the Warburg effect: Sweet temptation61
Direct and indirect effects on child neurocognitive development when maternal cancer is diagnosed during pregnancy: What do we know so far?60
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era58
Hurrying up but not rushing, acting and not reacting, good sense and not common sense: Open thoughts and reasonable doubts on COVID-19 vaccination strategies in cancer patients54
Instruments and scales for the evaluation of acute radiation dermatitis: A systematic review53
Editorial Board49
Surface-Enhanced Raman Scattering (SERS) combined with machine learning enables accurate diagnosis of cervical cancer: From molecule to cell to tissue level46
Letter to the Editor regarding the article “A net-work meta-analysis of the cardiac safety for next-generation hormonal agents in treating castration-resistant prostate cancer: How to choose drugs app46
Mapping the research landscape of HPV-positive oropharyngeal cancer: a bibliometric analysis45
Stereotactic body radiation therapy versus conventional external beam radiation therapy for painful bone metastases: A systematic review and meta-analysis of randomized trials43
Unveiling the Role of JAK2/STAT3 signaling in chemoresistance of gynecological cancers: From mechanisms to therapeutic implications42
Efficacy of PD-1/PD-L1 immunotherapy on brain metastatic non-small-cell lung cancer and treatment-related adverse events: A systematic review41
Navigating management of localized prostate cancer in the geriatric population40
The cytokines in tumor microenvironment: from cancer initiation-elongation-progression to metastatic outgrowth40
A bone paradigm challenging the standard model of myeloma oncogenesis40
Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions39
Skin barrier dysfunction in cutaneous T-cell lymphoma: From pathogenic mechanism of barrier damage to treatment39
Total neoadjuvant treatment and organ preservation strategies in the management of localized rectal cancer: A narrative review and evidence-based algorithm39
Dysregulation of systemic immunity in colorectal cancer and its clinical applications as biomarkers and therapeutics39
Optimal treatment strategy for central nervous system non-germinomatous germ cell tumors: A systematic review and meta-analysis38
UGT1A1 Testing in Breast Cancer: should it become routine practice in patients treated with antibody-drug conjugates?38
0.30037403106689